BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30208489)

  • 1. Gadolinium Retention After Contrast-Enhanced MRI.
    Levine D; McDonald RJ; Kressel HY
    JAMA; 2018 Nov; 320(18):1853-1854. PubMed ID: 30208489
    [No Abstract]   [Full Text] [Related]  

  • 2. Free gadolinium is a likely trigger of nephrogenic systemic fibrosis.
    Abraham JL; Edward M
    AJR Am J Roentgenol; 2009 Oct; 193(4):W354; author reply W355. PubMed ID: 19770307
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the Food and Drug Administration.
    Yang L; Krefting I; Gorovets A; Marzella L; Kaiser J; Boucher R; Rieves D
    Radiology; 2012 Oct; 265(1):248-53. PubMed ID: 22923714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging: does a US Food and Drug Administration alert influence practice patterns in CKD?
    Martin DR
    Am J Kidney Dis; 2010 Sep; 56(3):427-30. PubMed ID: 20728788
    [No Abstract]   [Full Text] [Related]  

  • 5. Administration of gadolinium-based contrast agents in MR angiography.
    Lin K
    AJR Am J Roentgenol; 2009 Apr; 192(4):W193; author reply W194. PubMed ID: 19304680
    [No Abstract]   [Full Text] [Related]  

  • 6. Gadolinium and nephrogenic systemic fibrosis: have the alarm bells been silenced?
    Tamburrini O; Balducci A
    Radiol Med; 2012 Feb; 117(1):1-5. PubMed ID: 22020430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium accumulation after contrast-enhanced magnetic resonance imaging: what rheumatologists should know.
    Doniselli FM; Albano D; Chianca V; Cimmino MA; Sconfienza LM
    Clin Rheumatol; 2017 May; 36(5):977-980. PubMed ID: 28321569
    [No Abstract]   [Full Text] [Related]  

  • 8. Gadolinium Retention and Breast MRI Screening: More Harm Than Good?
    Sardanelli F; Cozzi A; Trimboli RM; Schiaffino S
    AJR Am J Roentgenol; 2020 Feb; 214(2):324-327. PubMed ID: 31799869
    [No Abstract]   [Full Text] [Related]  

  • 9. Gadolinium and nephrogenic systemic fibrosis.
    Runge VM
    AJR Am J Roentgenol; 2009 Apr; 192(4):W195-6; discussion W197. PubMed ID: 19304681
    [No Abstract]   [Full Text] [Related]  

  • 10. Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network.
    Stratta P; Canavese C; Quaglia M; Fenoglio R
    Rheumatology (Oxford); 2010 Apr; 49(4):821-3. PubMed ID: 20032228
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrogenic systemic fibrosis.
    Weinreb JC; Kuo PH
    Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction to the relative risk calculation for gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis.
    Jain R; Levine M
    Radiology; 2010 Apr; 255(1):307-8; author reply 308. PubMed ID: 20308469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nephrogenic systemic fibrosis: a severe complication of use to gadolinium in patients with kidney failure].
    Mundim JS; Lorena Sde C; Abensur H; Elias RM; Moysés RM; Castro MC; Romão Júnior JE
    Rev Assoc Med Bras (1992); 2009; 55(2):220-5. PubMed ID: 19488662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium - 1997-2006-2016. Part 1.
    Thomsen HS
    Acta Radiol; 2016 May; 57(5):515-20. PubMed ID: 26802069
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal function, nephrogenic systemic fibrosis and other adverse reactions associated with gadolinium-based contrast media.
    Canga A; Kislikova M; Martínez-Gálvez M; Arias M; Fraga-Rivas P; Poyatos C; de Francisco AL
    Nefrologia; 2014; 34(4):428-38. PubMed ID: 25036056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on contrast-associated nephrogenic systemic fibrosis.
    Partain CL
    J Magn Reson Imaging; 2009 Dec; 30(6):1231-2. PubMed ID: 19938033
    [No Abstract]   [Full Text] [Related]  

  • 17. Special issue: nephrogenic systemic fibrosis.
    Leiner T; Kucharczyk W
    J Magn Reson Imaging; 2009 Dec; 30(6):1233-5. PubMed ID: 19938034
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
    Jikki PN
    J Assoc Physicians India; 2008 Nov; 56():915-6. PubMed ID: 19263697
    [No Abstract]   [Full Text] [Related]  

  • 19. Gadolinium contrast media during pregnancy and lactation.
    Webb JA; Thomsen HS
    Acta Radiol; 2013 Jul; 54(6):599-600. PubMed ID: 23966544
    [No Abstract]   [Full Text] [Related]  

  • 20. Can gadolinium be given safely to a patient on dialysis?
    Rodby RA
    Semin Dial; 2011; 24(4):370-1. PubMed ID: 21801214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.